Suppr超能文献

尤文肉瘤和骨肉瘤具有不同的免疫特征和细胞间通讯网络。

Ewing Sarcoma and Osteosarcoma Have Distinct Immune Signatures and Intercellular Communication Networks.

机构信息

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania.

出版信息

Clin Cancer Res. 2022 Nov 14;28(22):4968-4982. doi: 10.1158/1078-0432.CCR-22-1471.

Abstract

PURPOSE

Ewing sarcoma and osteosarcoma are primary bone sarcomas occurring most commonly in adolescents. Metastatic and relapsed disease are associated with dismal prognosis. Although effective for some soft tissue sarcomas, current immunotherapeutic approaches for the treatment of bone sarcomas have been largely ineffective, necessitating a deeper understanding of bone sarcoma immunobiology.

EXPERIMENTAL DESIGN

Multiplex immunofluorescence analysis of immune infiltration in relapsed versus primary disease was conducted. To better understand immune states and drivers of immune infiltration, especially during disease progression, we performed single-cell RNA sequencing (scRNAseq) of immune populations from paired blood and bone sarcoma tumor samples.

RESULTS

Our multiplex immunofluorescence analysis revealed increased immune infiltration in relapsed versus primary disease in both Ewing sarcoma and osteosarcoma. scRNAseq analyses revealed terminally exhausted CD8+ T cells expressing co-inhibitory receptors in osteosarcoma and an effector T-cell subpopulation in Ewing sarcoma. In addition, distinct subsets of CD14+CD16+ macrophages were present in Ewing sarcoma and osteosarcoma. To determine pathways driving tumor immune infiltration, we conducted intercellular communication analyses and uncovered shared mechanisms of immune infiltration driven by CD14+CD16+ macrophages and unique pathways of immune infiltration driven by CXCL10 and CXCL12 in osteosarcoma.

CONCLUSIONS

Our study provides preclinical rationale for future investigation of specific immunotherapeutic targets upon relapse and provides an invaluable resource of immunologic data from bone sarcomas.

摘要

目的

尤文肉瘤和骨肉瘤是最常见于青少年的原发性骨肉瘤。转移性和复发性疾病与预后不良相关。尽管某些软组织肉瘤的治疗有效,但目前针对骨肉瘤的免疫治疗方法在很大程度上无效,因此需要更深入地了解骨肉瘤的免疫生物学。

实验设计

对复发性与原发性疾病的免疫浸润进行了多重免疫荧光分析。为了更好地了解免疫状态和免疫浸润的驱动因素,特别是在疾病进展过程中,我们对配对的血液和骨肉瘤肿瘤样本中的免疫群体进行了单细胞 RNA 测序(scRNAseq)。

结果

我们的多重免疫荧光分析显示,尤文肉瘤和骨肉瘤的复发性疾病比原发性疾病的免疫浸润更多。scRNAseq 分析显示,骨肉瘤中表达共抑制受体的终末耗竭 CD8+T 细胞和尤文肉瘤中的效应 T 细胞亚群。此外,尤文肉瘤和骨肉瘤中存在不同的 CD14+CD16+巨噬细胞亚群。为了确定驱动肿瘤免疫浸润的途径,我们进行了细胞间通讯分析,并发现了 CD14+CD16+巨噬细胞驱动免疫浸润的共享机制,以及骨肉瘤中由 CXCL10 和 CXCL12 驱动免疫浸润的独特途径。

结论

我们的研究为复发后针对特定免疫治疗靶点的进一步研究提供了临床前依据,并为骨肉瘤的免疫学数据提供了宝贵的资源。

相似文献

引用本文的文献

9
Data standards for single-cell RNA-sequencing of paediatric cancer.儿童癌症单细胞RNA测序的数据标准
Clin Transl Immunology. 2025 May 23;14(5):e70033. doi: 10.1002/cti2.70033. eCollection 2025 May.

本文引用的文献

1
Clinical relevance of tumour-associated macrophages.肿瘤相关巨噬细胞的临床相关性。
Nat Rev Clin Oncol. 2022 Jun;19(6):402-421. doi: 10.1038/s41571-022-00620-6. Epub 2022 Mar 30.
6
New Horizons in the Treatment of Osteosarcoma.骨肉瘤治疗的新视野
N Engl J Med. 2021 Nov 25;385(22):2066-2076. doi: 10.1056/NEJMra2103423.
7
Targeting CD47 for cancer immunotherapy.针对 CD47 的癌症免疫疗法。
J Hematol Oncol. 2021 Oct 30;14(1):180. doi: 10.1186/s13045-021-01197-w.
10
Monocyte Regulation in Homeostasis and Malignancy.单核细胞在稳态和恶性肿瘤中的调控。
Trends Immunol. 2021 Feb;42(2):104-119. doi: 10.1016/j.it.2020.12.001. Epub 2021 Jan 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验